Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 3
2002 3
2004 4
2005 11
2006 8
2007 7
2008 8
2009 9
2010 4
2011 1
2012 2
2013 7
2014 6
2015 7
2016 6
2017 12
2018 13
2019 2
2020 9
2021 31
2022 16
2023 14
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, Gerolami R, Masi G, Ross PJ, Song T, Bronowicki JP, Ollivier-Hourmand I, Kudo M, Cheng AL, Llovet JM, Finn RS, LeBerre MA, Baumhauer A, Meinhardt G, Han G; RESORCE Investigators. Bruix J, et al. Among authors: granito a. Lancet. 2017 Jan 7;389(10064):56-66. doi: 10.1016/S0140-6736(16)32453-9. Epub 2016 Dec 6. Lancet. 2017. PMID: 27932229 Clinical Trial.
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Pelizzaro F, Ramirez Morales R, Cillo U, Trevisani F, Miele L, Marchesini G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Vitale A, et al. Gut. 2023 Jan;72(1):141-152. doi: 10.1136/gutjnl-2021-324915. Epub 2021 Dec 21. Gut. 2023. PMID: 34933916
Regorafenib for the treatment of hepatocellular carcinoma.
Tovoli F, Granito A, De Lorenzo S, Bolondi L. Tovoli F, et al. Among authors: granito a. Drugs Today (Barc). 2018 Jan;54(1):5-13. doi: 10.1358/dot.2018.54.1.2736667. Drugs Today (Barc). 2018. PMID: 29569657 Review.
COVID-19: Has the Liver Been Spared?
Brandi N, Spinelli D, Granito A, Tovoli F, Piscaglia F, Golfieri R, Renzulli M. Brandi N, et al. Among authors: granito a. Int J Mol Sci. 2023 Jan 6;24(2):1091. doi: 10.3390/ijms24021091. Int J Mol Sci. 2023. PMID: 36674607 Free PMC article. Review.
Contrast-enhanced ultrasound liver imaging reporting and data system: clinical validation in a prospective multinational study in North America and Europe.
Lyshchik A, Wessner CE, Bradigan K, Eisenbrey JR, Forsberg F, Yi M, Keith SW, Kono Y, Wilson SR, Medellin A, Rodgers SK, Planz V, Kamaya A, Finch L, Fetzer DT, Berzigotti A, Sidhu PS, Piscaglia F; CEUS LI-RADS Trial Group. Lyshchik A, et al. Hepatology. 2024 Feb 1;79(2):380-391. doi: 10.1097/HEP.0000000000000558. Epub 2023 Aug 8. Hepatology. 2024. PMID: 37548928
HCV and autoimmunity.
Ferri S, Muratori L, Lenzi M, Granito A, Bianchi FB, Vergani D. Ferri S, et al. Among authors: granito a. Curr Pharm Des. 2008;14(17):1678-85. doi: 10.2174/138161208784746824. Curr Pharm Des. 2008. PMID: 18673191 Review.
168 results